Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Qi, Xue"'
Autor:
Fan, Zhang, Bin, Qiu, Ying, Ji, Hao, Zhang, Peng, Song, Nan, Sun, Liang, Zhao, Fang, Lv, Lixia, Yin, Yibo, Gao, Qi, Xue, Shugeng, Gao, Jie, He
Publikováno v:
Cell cycle (Georgetown, Tex.). 22(2)
Lung cancer has been recognized as the most common malignant neoplasm of the respiratory system with extremely high morbidity, among which non-small cell lung cancer (NSCLC) accounts for the majority. Many published literatures have revealed the role
Autor:
Zi‐mu Mao, Zhen‐wei Wang, Chao Xu, Chen‐he Liu, Zhi‐yu Zhang, Xiao‐li Ren, An‐qi Xue, Ze‐nan Li, Feng Zhao, Qi Yao, Jia‐kuo Yu
Publikováno v:
Orthopaedic Surgery. 14:3367-3377
The debate on the superiority of single- or double-bundle for anterior cruciate ligament reconstruction has not ceased. The comparative studies on intra-articular biomechanics after different surgical reconstructions are rare. This study is to evalua
Autor:
Fengwei Tan, Nan Bi, Hao Zhang, Renda Li, Zhijie Wang, Jianchun Duan, Feng Jiang, Dongjie Feng, Rongsheng Zhang, Junjun Bai, Jianzhong Cao, Naiquan Mao, Kai Liang, Shiquan Yin, Yaxing Shen, Feiyue Feng, Jun Zhao, Yushun Gao, Yousheng Mao, Qi Xue, Shugeng Gao, Jie He
Publikováno v:
Lung Cancer. 170:98-104
The newly released eighth edition of the American Joint Committee on Cancer TNM staging system for lung cancer seeks to improve prognostic accuracy but lacks external validation for small cell lung cancer (SCLC). Moreover, previous studies posed a fe
Autor:
Fan Zhang, Wei Guo, Bolun Zhou, Shuhang Wang, Ning Li, Bin Qiu, Fang Lv, Liang Zhao, Jian Li, Kang Shao, Qi Xue, Shugeng Gao, Jie He
Publikováno v:
Journal of Thoracic Oncology. 17:909-920
Programmed cell death protein-1 (PD-1) inhibitors have been proved to be feasible and to have efficacy in multiple cancers, including NSCLC. But few studies have evaluated the effectiveness of PD-1 inhibitor as neoadjuvant therapy with a long-term fo
Autor:
Xingkai Li, Hengchi Chen, Lizhen Zhang, Li Chen, Wei Wei, Shugeng Gao, Qi Xue, Yue Li, Bing Wang, Jiagen Li, Yushun Gao, Yanliang Lin
Publikováno v:
Oncogene. 41:2685-2695
Dietary cholesterol has been implicated to promote lung cancer. Lung adenocarcinoma (LAC) is a main type of lung cancer, whereas the functional mechanism of cholesterol in LAC remained largely unknown. In the present study, we evidenced that choleste
Publikováno v:
Bioengineered, Vol 13, Iss 2, Pp 2828-2840 (2022)
Elevated evidences manifest that circular RNAs (circRNAs) are vital in human tumor advancement and chemotherapy resistance. The study was to explore the character of Circ-CUL2 in non-small cell lung cancer (NSCLC). Firstly, the expression of circ-CUL
Publikováno v:
BMC Anesthesiology, Vol 22, Iss 1, Pp 1-8 (2022)
BMC Anesthesiology
BMC Anesthesiology
Background Accurate prediction of the difficult airway (DA) could help to prevent catastrophic consequences in emergency resuscitation, intensive care, and general anesthesia. Until now, there is no nomogram prediction model for DA based on ultrasoun
Autor:
Ying Ji, Hua Bao, Shugeng Gao, Qi Xue, Wei Guo, Yang Xu, Jie He, Fan Zhang, Xiaoxi Chen, Fengwei Tan, Yue Peng, Bin Qiu, Fang Lv, Yang Shao
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Nature Communications
Nature Communications
Accurately evaluating minimal residual disease (MRD) could facilitate early intervention and personalized adjuvant therapies. Here, using ultradeep targeted next-generation sequencing (NGS), we evaluate the clinical utility of circulating tumor DNA (
Autor:
Jie He, Qi Xue, Xiaoxiang Zhou, Fengwei Tan, Kailun Fei, Jianchun Duan, Jie Wang, Shugeng Gao, Hua Bai, Zhang Zhen, Jiachen Xu, Xin Wang, Zhuoran Yao, Yibo Gao, Xue Zhang, Zhijie Wang
Publikováno v:
The Lancet Oncology. 22:1265-1274
Summary Background Numerous ongoing trials are testing anti-PD-1-based or anti-PD-L1-based cancer treatment combinations. Understanding the toxicity profiles of treatment-related adverse events is essential. The aim of this study was to comprehensive
Autor:
Kai Sun, Ling Qiu, Xiaochuang Feng, Haijun Deng, Yijia Lu, Wenbo Zheng, Qi Xue, Chunzhao Yang
Publikováno v:
Cancer Medicine, Vol 10, Iss 17, Pp 5998-6009 (2021)
Cancer Medicine
Cancer Medicine
Colorectal cancer (CRC) is a malignant tumor and morbidity rates are among the highest in the world. The variation in CRC patients' prognosis prompts an urgent need for new molecular biomarkers to improve the accuracy for predicting the CRC patients'